Skip to content

Inlay versus brace treatment for medial knee osteoarthritis. A randomised trial.

Lateral wedge sole versus knee brace in the treatment of unicompartmental knee osteoarthritis. A randomised trial.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON27633
Enrollment
100
Registered
2005-09-15
Start date
2005-10-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Group I: laterale wedge sole (inlay)
Group II: valgisation knee brace (brace).

Sponsors

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients (male and female) with symptomatic medial osteoarthritis of the knee are included. Patients will be included after informed consent given and baseline measurements made.

Exclusion criteria

Exclusion criteria: Exclusion criteria are below 35 or above 60 years of age, symptoms not related to medial osteoarthritis of the knee or not able to speak or understand Dutch.

Design outcomes

Primary

MeasureTime frame
Will inlay treatment for patients with symptomatic medial knee ostearthritis yield better results then brace treatment? Measurements: 1. Painscore (VAS); 2. Hospital for Special Surgery (HHS) Knee Service Rating System; 3. Western Ontario and McMaster University Osteoarthritis Index (WOMAC).

Secondary

MeasureTime frame
I- Will there be a functional diference between both groups? Measurements: 1. Gait analysis (knee adduction moment, toeing-out, knee extension moment); 2. Knee range of motion; 3. Patient satisfaction; 4. Maxmium walking distance II – Will conservative treatment (inlay or brace) give a favourable outcome for medial knee osteoarthritis? Measurements: 5. Dual energy x-ray absorptiometry (DEXA-scan); 6. Osteoarthritis markers (serum and urine); 7. Hip-knee-ankel (HKA)angle.

Contacts

Public ContactT.M. Raaij, van

Erasmus University Medical Center, Department of Orthopaedic Surgery, P.O. Box 2040

t.vanraaij@chello.nl

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)